BRIAN S. POSNER - Corporate Board Profile

ARCH CAPITAL GROUP LTD.

Filing Date	Source Excerpt
2013-03-29	The table below provides information concerning the compensation of the directors for fiscal year 2012. Brian S. Posner 122,575 75,000 6 6 6 197,575
2014-03-27	Brian S. Posner has been a director of the Company since November 2010. ... He is a member of the Underwriting Oversight Committee and Audit Committee. ... The compensation table shows Brian S. Posner with total compensation of $199,996 for 2013.
2015-03-26	Brian S. Posner has been a director of the Company since November 2010. Mr. Posner has been a private investor since March 2008 and is the President of Point Rider Group LLC, a consulting and advisory services firm within the financial services industry. From 2005 to March 2008, Mr. Posner served as the Chief Executive Officer and Co-Chief Investment Officer of ClearBridge Advisors, LLC, an asset management company and a wholly owned subsidiary of Legg Mason. Prior to that, Mr. Posner co-founded Hygrove Partners LLC, a private investment fund, in 2000 and served as the Managing Member for five years. He served as a portfolio manager and an analyst at Fidelity Investments from 1987 to 1996 and, from 1997 to 1999, at Warburg Pincus Asset Management/Credit Suisse Asset Management where he also served as co-chief investment officer and director of research. Mr. Posner currently serves on the boards of directors of Biogen Idec Inc., BG Medicine Inc. and The Mutual Fund Store, and he is a trustee of the AQR funds. He holds a B.A. from Northwestern University and an M.B.A. from the University of Chicago Booth School of Business. Mr. Posner’s qualifications for service on our Board include his strong financial background, investment skills and extensive experience as a leading institutional investment manager and advisor.
2016-03-23	Brian S. Posner has been a director of the Company since November 2010. ... The audit committee currently consists of Brian S. Posner (chairman), Yiorgos Lillikas, Louis J. Paglia and Eugene S. Sunshine. ... The underwriting oversight committee currently consists of John D. Vollaro (chairman), Yiorgos Lillikas, Louis J. Paglia, John M. Pasquesi and Brian S. Posner. ... The finance, investment and risk committee currently consists of John M. Pasquesi (chairman), John L. Bunce, Jr., Eric W. Doppstadt, Constantine Iordanou, Kewsong Lee, Deanna M. Mulligan, Brian S. Posner and John D. Vollaro. ... The table below provides information concerning the compensation of our directors for fiscal year 2015. ... Brian S. Posner Fees Earned or Paid in Cash: 183,023; Stock Awards: 74,990; All Other Compensation: 50,000; Total: 308,013.
2017-03-24	Brian S. Posner has been a director of the Company since November 2010. Mr. Posner has been a private investor since March 2008 and is the President of Point Rider Group LLC, a consulting and advisory services firm within the financial services industry. From 2005 to March 2008, Mr. Posner served as the President, Chief Executive Officer and Co-Chief Investment Officer of ClearBridge Advisors, LLC, an asset management company and a wholly owned subsidiary of Legg Mason. Prior to that, Mr. Posner co-founded Hygrove Partners LLC, a private investment fund, in 2000 and served as the Managing Member for five years. He served as a portfolio manager and an analyst at Fidelity Investments from 1987 to 1996 and, from 1997 to 1999, at Warburg Pincus Asset Management/Credit Suisse Asset Management where he also served as Co-Chief Investment Officer and director of research. Mr. Posner currently serves on the boards of directors of Biogen Inc. and Bioverativ Inc. and he is a trustee of the AQR Funds. He holds a B.A. from Northwestern University and an M.B.A. from the University of Chicago Booth School of Business. Mr. Posner’s qualifications for service on our Board include his strong financial background, investment skills and extensive experience as a leading institutional investment manager and advisor.
2018-03-28	Brian S. Posner, 56 years old, Class I Director of Arch Capital, Audit Committee Chair, Finance, Investment and Risk Committee, Underwriting Oversight Committee. Compensation: $329,461.
2019-03-28	Mr. Posner has been a private investor since March 2008. Director since November 2010. Serves on Audit Committee, Finance, Investment and Risk Committee, Underwriting Oversight Committee. Director Compensation: $349,505 total.
2020-03-27	Brian S. Posner, 58 years old, Director since November 2010, Class I Director of Arch Capital, Audit Committee, Nominating and Governance Committee, Underwriting Oversight Committee. Total compensation: $349,547.
2021-03-26	Brian S. Posner, 59 years old, Director since November 2010, Class I Director of Arch Capital, Audit Committee, Nominating and Governance Committee, Underwriting Oversight Committee. Mr. Posner is President of Point Rider Group LLC.
2023-03-23	Mr. Posner has been a private investor since March 2008... Director since November 2010... Audit Committee, Finance, Investment and Risk Committee... Total compensation $329,996.
2024-03-28	Brian S. Posner is President of Point Rider Group LLC. Director since November 2010. Class I Director of Arch Capital. Compensation and Human Capital Committee, Finance, Investment and Risk Committee Chair. Compensation: $302,492.

BIOGEN INC.

Filing Date	Source Excerpt
2014-04-30	Brian S. Posner Age: 52 Director since: 2008 Committee Memberships: Corporate Governance, Finance and Audit
2015-04-30	Brian S. Posner Age: 53 Committee Memberships: Audit, Corporate Governance, Finance (Chair) Mr. Posner has served as one of our directors since 2008.
2016-04-15	Mr. Posner, 54, has served as one of our directors since 2008. Mr. Posner has been a private investor since March 2008 and is the President of Point Rider Group LLC, a consulting and advisory services firm within the financial services industry. From 2005 to March 2008, Mr. Posner served as the President, Chief Executive Officer and co-Chief Investment Officer of ClearBridge Advisors LLC, an asset management company and a wholly-owned subsidiary of Legg Mason. Prior to that, Mr. Posner co-founded Hygrove Partners LLC, a private investment fund, in 2000 and served as its Managing Partner for five years. He served as a portfolio manager and an analyst at Fidelity Investments, a financial services company, from 1987 to 1996 and, from 1997 to 1999, at Warburg Pincus Asset Management/Credit Suisse Asset Management where he also served as co-Chief Investment Officer and Director of Research. Given his substantial experience as a leading institutional investment manager and advisor, Mr. Posner brings a professional investor's perspective and significant management and financial expertise that is valuable to our Board of Directors as it oversees our strategy for enhancing stockholder value. Biogen Committee Memberships: Finance (Chair), Audit, Corporate Governance. 2015 Director Compensation: $448,508.
2017-04-26	Mr. Posner, 55, has served as one of our directors since 2008. Mr. Posner has been a private investor since March 2008 and is the President of Point Rider Group LLC, a consulting and advisory services firm serving predominantly the financial services industry. Biogen Committee Memberships: Finance (Chair), Audit, Corporate Governance. 2016 Director Compensation: $480,420.
2018-04-27	Mr. Posner, 56, has served as one of our directors since 2008. Mr. Posner has been a private investor since March 2008 and is the President of Point Rider Group LLC, a consulting and advisory services firm serving predominantly the financial services industry, as well as institutional investors seeking to make control investments in that industry. From 2005 to March 2008, Mr. Posner served as the President, Chief Executive Officer and co-Chief Investment Officer of ClearBridge Advisors LLC, an asset management company and a wholly-owned subsidiary of Legg Mason. Prior to that, Mr. Posner co-founded Hygrove Partners LLC, a private investment fund, in 2000 and served as its Managing Partner for five years. He served as a portfolio manager and an analyst at Fidelity Investments, a financial services company, from 1987 to 1996 and, from 1997 to 1999, at Warburg Pincus Asset Management/Credit Suisse Asset Management where he also served as co-Chief Investment Officer and Director of Research. Mr. Posner also serves as a director of AQR Funds and Arch Capital Group Ltd., a specialty insurance and reinsurance provider. Given his substantial experience as a leading institutional investment manager and advisor, Mr. Posner brings a professional investor’s perspective and significant management and financial expertise that are valuable to our Board of Directors as it oversees our strategy for enhancing stockholder value. Biogen Committee Memberships: Finance (Chair), Audit, Corporate Governance. 2017 Director Compensation: $450,479.
2019-04-30	Mr. Posner has been a private investor since March 2008 and is the founder and Managing Partner of Point Rider Group LLC, a boutique consulting and advisory services firm that provides customized solutions to senior executives and boards of financial, bio-pharmaceutical and other services-related companies, as well as strategic investors that make, direct and control investments in those sectors.
2020-04-20	Mr. Posner has been a private investor since March 2008... Biogen Board Committee: Compensation and Management Development... 2019 Director Compensation: Brian S. Posner total $444,643.
2021-04-23	Mr. Posner is a private investor and founder of Point Rider Group LLC... Biogen Board Committee: Compensation and Management Development... 2020 Director Compensation: Brian S. Posner total $434,314.